Other substances

Valrubicin

A doxorubicin derivative.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
3
 AI-suggested references
0
 Clinical trials

General information

Valrubicin on PubChem

Marketed as

VALSTAR; VALTAXIN

 

Structure image - Valrubicin

CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O

Supporting references

Link Tested on Impact factor Notes Publication date
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
ACE2 TMPRSS2 Small molecule In silico 		in silico 3.26

Predicted to target both TMPRSS2 and ACE2.

 Feb/02/2021

AI-suggested references

Link Publication date
Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation.
Mar/01/2022
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
Jul/13/2021
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Mar/25/2022
Export (.csv)